SciClone Pharmaceuticals IPO Valuation: Not Pleasing
SciClone has set the terms for its IPO, where it plans to issue approx. 116m shares at an indicative IPO price range of HK$17.2-18.8 per share to...
377 Views
ECM Weekly (21 February 2021) - Tencent Lock-Up Expiry, SciClone Pharma, Joinn Lab, Bairong, Betta
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
679 Views
SciClone Pharmaceuticals IPO: Valuation Insights
SciClone has launched its IPO to raise net proceeds of $252m, at the mid-point of the price range. We recommend a pass as our concerns on the...
963 Views
SciClone (赛生药业) IPO: A Mediocre Deal
We think the cornerstone is mediocre and the deal is fairly valued. The recent reference deal of its close peer, Simcere, has done poorly. We will...
612 Views
JOINN Laboratories IPO: Attractive Valuation; Overseas Expansion Should Open Up Room for LT Growth
Joinn Laboratories, the pioneer of commercial GLP laboratories in China has filed for a secondary listing to list its shares on the Hong Kong Stock...
337 Views